LATEST
TRENDING
EDITORS CHOICE
Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia
European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia
Phexxi; Have You Heard About This New Hormone-Free Contraceptive?
She is sick of using birth control, but now is not the right time to get pregnant. The “pull and pray” method is too...
FDA Approval of New Drug for Alzheimer’s Offers Hope
The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.
Opdivo® Approved for the Treatment of Advanced Esophageal Squamous Cell Carcinoma
FDA Approved Opdivo demonstrated superior overall survival benefit compared to docetaxel or paclitaxel in ESCC Patients